Alpha Teknova Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Alpha Teknova wird ein jährliches Gewinn- und Umsatzwachstum von 31.4% bzw. 18.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 45.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich -19.4% betragen.

Wichtige Informationen

31.4%

Wachstumsrate der Gewinne

45.2%

EPS-Wachstumsrate

Life Sciences Gewinnwachstum	18.1%
Wachstumsrate der Einnahmen	18.3%
Zukünftige Eigenkapitalrendite	-19.4%
Analystenabdeckung	Low
Zuletzt aktualisiert	14 Aug 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Alpha Teknova, Inc. (NASDAQ:TKNO) Might Not Be As Mispriced As It Looks After Plunging 30%

Jun 27

Not Many Are Piling Into Alpha Teknova, Inc. (NASDAQ:TKNO) Stock Yet As It Plummets 25%

Apr 24

Health Check: How Prudently Does Alpha Teknova (NASDAQ:TKNO) Use Debt?

Jan 22

Some Analysts Just Cut Their Alpha Teknova, Inc. (NASDAQ:TKNO) Estimates

Aug 14

Take Care Before Jumping Onto Alpha Teknova, Inc. (NASDAQ:TKNO) Even Though It's 30% Cheaper

Apr 17

Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported, And Analysts Assigned A US$23.00 Price Target

May 14

Gewinn- und Umsatzwachstumsprognosen

NasdaqGM:TKNO - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	58	-14	-4	-1	2
12/31/2025	43	-21	-9	-6	5
12/31/2024	37	-25	-17	-15	5
6/30/2024	35	-34	-18	-17	N/A
3/31/2024	37	-36	-21	-18	N/A
12/31/2023	37	-37	-27	-19	N/A
9/30/2023	37	-39	-36	-24	N/A
6/30/2023	39	-52	-46	-28	N/A
3/31/2023	39	-51	-56	-30	N/A
12/31/2022	41	-47	-56	-27	N/A
9/30/2022	44	-38	-53	-22	N/A
6/30/2022	42	-19	-47	-19	N/A
3/31/2022	39	-15	-39	-17	N/A
12/31/2021	37	-10	-29	-9	N/A
9/30/2021	37	-6	-20	-4	N/A
6/30/2021	37	-3	-13	0	N/A
3/31/2021	34	0	-4	5	N/A
12/31/2020	31	1	-3	3	N/A
12/31/2019	21	-1	0	2	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: TKNO wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: TKNO wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: TKNO wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: TKNODie Einnahmen des Unternehmens (18.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.8% pro Jahr).

Hohe Wachstumseinnahmen: TKNODie Einnahmen des Unternehmens (18.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: TKNO wird voraussichtlich in 3 Jahren unrentabel sein.

Alpha Teknova Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Alpha Teknova, Inc. Re-Iterates Earnings Guidance for the Full Year Ending December 31, 2024

Consensus EPS estimates upgraded to US$0.71 loss, revenue downgraded

Alpha Teknova, Inc. Reiterates Revenue Guidance for Fiscal 2024

Price target increased by 13% to US$6.00

No longer forecast to breakeven

Alpha Teknova, Inc. Provides Revenue Guidance for the Fiscal Year Ending December 31, 2023

Recent updates

Alpha Teknova, Inc. Re-Iterates Earnings Guidance for the Full Year Ending December 31, 2024

Alpha Teknova, Inc. announced that it expects to receive $15.358495 million in funding

Alpha Teknova, Inc. to Report Q2, 2024 Results on Aug 13, 2024

Alpha Teknova, Inc. (NASDAQ:TKNO) Might Not Be As Mispriced As It Looks After Plunging 30%

Consensus EPS estimates upgraded to US$0.71 loss, revenue downgraded

Alpha Teknova, Inc. Reiterates Revenue Guidance for Fiscal 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 13% to US$6.00

Alpha Teknova, Inc., Annual General Meeting, Jun 24, 2024

Not Many Are Piling Into Alpha Teknova, Inc. (NASDAQ:TKNO) Stock Yet As It Plummets 25%

New minor risk - Market cap size

No longer forecast to breakeven

Alpha Teknova, Inc. Announces Impairment Charges for the Fourth Quarter Ended December 31, 2023

Full year 2023 earnings released: US$1.16 loss per share (vs US$1.69 loss in FY 2022)

Alpha Teknova, Inc. to Report Q4, 2023 Results on Mar 11, 2024

Health Check: How Prudently Does Alpha Teknova (NASDAQ:TKNO) Use Debt?

Alpha Teknova, Inc. Announces Termination of Certain Executive Officers, Effective from March 1, 2024

Alpha Teknova, Inc. Provides Revenue Guidance for the Fiscal Year Ending December 31, 2023

Third quarter 2023 earnings: EPS misses analyst expectations

Alpha Teknova, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Alpha Teknova, Inc. has completed a Follow-on Equity Offering in the amount of $2.009997 million.

New minor risk - Shareholder dilution

Alpha Teknova, Inc. announced that it expects to receive $20.904987 million in funding

Alpha Teknova, Inc. announced that it expects to receive $20.904987 million in funding

Alpha Teknova, Inc. Announces the Appointment of Martha J. Demski to Its Board of Directors

New major risk - Share price stability

Some Analysts Just Cut Their Alpha Teknova, Inc. (NASDAQ:TKNO) Estimates

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Alpha Teknova, Inc. Provides Revenue Guidance for the Fiscal 2023

Alpha Teknova, Inc. to Report Q2, 2023 Results on Aug 10, 2023

Alpha Teknova, Inc. Expands Proprietary Aav-Tek Solutions Product Line to Deliver End-To-End Solutions for Gene Therapy Process Development

Price target decreased by 9.1% to US$7.50

First quarter 2023 earnings released: US$0.31 loss per share (vs US$0.20 loss in 1Q 2022)

Take Care Before Jumping Onto Alpha Teknova, Inc. (NASDAQ:TKNO) Even Though It's 30% Cheaper

Full year 2022 earnings released: US$1.69 loss per share (vs US$0.61 loss in FY 2021)

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Price target decreased to US$10.00

Alpha Teknova, Inc. Announces Goodwill Impairment Charges for the Three Months Ended September 30, 2022

Alpha Teknova, Inc. to Report Q3, 2022 Results on Nov 09, 2022

Consensus forecasts updated

President recently bought US$92k worth of stock

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Alpha Teknova, Inc. Provides Revenue Guidance for Fiscal Year Ending December 31, 2022

Alpha Teknova, Inc. to Report Q2, 2022 Results on Aug 10, 2022

Alpha Teknova, Inc.(NasdaqGM:TKNO) dropped from Russell 2000 Growth Index

Chief Financial Officer recently bought US$94k worth of stock

Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported, And Analysts Assigned A US$23.00 Price Target

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Alpha Teknova, Inc. Provides Revenue Guidance for the Year Ending December 31, 2022

Alpha Teknova, Inc. to Report Q1, 2022 Results on May 11, 2022

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Alpha Teknova, Inc. Provides Revenue Guidance for the Fourth Quarter 2021

Chief People Officer exercised options to buy US$439k worth of stock.

Third quarter 2021 earnings released: US$0.12 loss per share

Director recently bought US$181k worth of stock

Alpha Teknova, Inc. has completed an IPO in the amount of $96 million.

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken